Alpine Immune
AcquiredLeading the Next Evolution of Immunotherapies
Seattle, United States · Founded 2014 · $108.0M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- alpineimmunesciences.com
- Total Funding
- $108.0M
- Last Round
- $60.0M Series BJan 2017
- Rounds
- 3
- Acquisition Date
- May 2024
About
Clinical-stage biotechnology company developing protein-based immunotherapies for cancer and autoimmune diseases; acquired by Vertex Pharmaceuticals.
Summary
Alpine Immune is a Biotech company based in Seattle, United States, founded in 2014. It has raised $108.0M in total across 3 rounds, most recently a $60.0M Series B round in Jan 2017. Investors include Omega Funds, Vertex Pharmaceuticals and OrbiMed.
Funding History
May 2024
Sign up to see all 6 rounds
Seed through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alpine-immune"><img src="https://indexed.vc/api/badge/company/alpine-immune" alt="Alpine Immune on Indexed.vc" width="260" height="76" /></a>